Market Research

 The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025). The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.

Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global forecasts to 2025

Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.

Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=516467241

Key Questions Addressed by the Report :

⏩ Where will these developments take the industry in the mid to long-term?
⏩ What types of annual and multi-year partnerships are companies in the digital therapeutics market exploring?
⏩ Who are the key players in the market, and how intense is the competition?
⏩ What are the recent contracts and agreements that key players have signed?
⏩ What are the recent trends affecting digital therapeutics market players?

Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724